Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Clinical trials show tirzepatide users achieve 2122% body weight reduction compared to semaglutide's 1317%, particularly in individuals whose genetic makeup predisposes them to stronger GIP-pathway responsiveness
This dosing regimen produced measurable senescent cell clearance and functional improvements including enhanced physical activity, improved kidney function markers, and restored fur quality
Key Research Highlights Dual-peptide blend pairing BPC-157 (pentadecapeptide) with TB-500 (Thymosin Beta-4 analogue) Studied in vitro for cytoskeletal / actin dynamics and cellular signaling interactions Used to investigate potential additive or synergistic effects of the two peptides at the molecular level 99% purity (individual components), independently verified by third-party HPLC testing COA available For research use only not for human or animal use WOLVERINE (BPC-157 5mg / TB-500 5mg) is supplied by Coastal Bio Labs as a research-grade compound for in vitro laboratory research use only
51 (4), 191 (1998) A
US$ 26.98
US$ 28.39
US$ 27.14
US$ 20.22
